PlainRecalls
FDA Drug Low Class III Terminated

Pain Relief Maximum Strength (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablets per packet, Manufactured for Select Corporation, Carrollton, TX 75007

Reported: August 26, 2020 Initiated: August 3, 2020 #D-1512-2020

Product Description

Pain Relief Maximum Strength (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablets per packet, Manufactured for Select Corporation, Carrollton, TX 75007

Reason for Recall

Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.

Details

Recalling Firm
Ultra Seal Corporation
Units Affected
4,666,355 packets
Distribution
Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.
Location
New Paltz, NY

Frequently Asked Questions

What product was recalled?
Pain Relief Maximum Strength (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablets per packet, Manufactured for Select Corporation, Carrollton, TX 75007. Recalled by Ultra Seal Corporation. Units affected: 4,666,355 packets.
Why was this product recalled?
Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 26, 2020. Severity: Low. Recall number: D-1512-2020.